Science
Mechanism of Action
As Epidermal Growth Factor (EGF), SR-OLIGOPEPTIDE-1 functions as a potent cellular signal molecule. It specifically binds to the epidermal growth factor receptor (EGFR), stimulating cell growth, proliferation, and differentiation. This action promotes skin repair and self-regeneration, enhances blood vessel formation, and stimulates endogenous rejuvenating growth factors. It also supports the proliferation of keratinocytes, endothelial cells, and fibroblasts, improving skin barrier function, moderating inflammatory responses, and minimizing scar formation. Furthermore, it contributes to long-term hydration and augments the production of vital extracellular matrix components such as collagen, elastin, and hyaluronic acid.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 Clinical assessments demonstrated statistically significant improvements in the appearance of fine lines, skin texture, pore size, and various dyschromatic conditions within one month, with sustained improvements over a three-month period.
- 02 Effective applications have been noted in accelerating wound healing for diabetic patients and managing Senile purpura.
- 03 Promotes epidermal cell growth, counteracts the thinning of aging skin, provides nourishment, smoothes complexion, lightens skin, rejuvenates tired skin, and assists in scar reduction.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
SR-OLIGOPEPTIDE-1 is highly sensitive to pH; the cream's pH must be adjusted to between 5.0 and 8.0 before adding the diluted solution. Maintaining its activity necessitates rigorous avoidance of microbial contamination during processing, as enzymes from microorganisms can degrade the polypeptide.
Safety
Safety Profile
Although authorized as a cosmetic ingredient for general use, the long-term risks of SR-OLIGOPEPTIDE-1 remain undefined. Its active bioequivalent, EGF, is considered a potent unauthorized drug, not approved for medical treatments outside of clinical trials. Significant concerns exist regarding its mitogenic (cell proliferation-stimulating) properties, which could potentially promote the spread of existing cancerous cells. Individuals with skin cancer risk factors, numerous moles, excessive UV exposure, or conditions like psoriasis are advised to exercise extreme caution or avoid products containing EGF. The scientific basis and preclinical bioactivity of some cosmetic studies on sh-oligopeptide-1 have been questioned. Data on topical usage during pregnancy and breastfeeding is lacking, requiring consultation with a healthcare professional.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite promising efficacy in skin rejuvenation and repair, the substantial safety concerns regarding its potential mitogenic activity on existing cancerous cells, regulatory ambiguity, and unknown long-term risks render SR-OLIGOPEPTIDE-1 a questionable ingredient for precision skincare.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources